Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.

Cancer cell | Aug 14, 2006

BRIT1, initially identified as an hTERT repressor, has additional functions at DNA damage checkpoints. Here, we demonstrate that BRIT1 formed nuclear foci minutes after irradiation. The foci of BRIT1 colocalized with 53BP1, MDC1, NBS1, ATM, RPA, and ATR. BRIT1 was required for activation of these elements, indicating that BRIT1 is a proximal factor in the DNA damage response pathway. Depletion of BRIT1 increased the accumulation of chromosomal aberrations. In addition, decreased levels of BRIT1 were detected in several types of human cancer, with BRIT1 expression being inversely correlated with genomic instability and metastasis. These results identify BRIT1 as a crucial DNA damage regulator in the ATM/ATR pathways and suggest that it functions as a tumor suppressor gene.

Pubmed ID: 16872911 RIS Download

Mesh terms: Base Sequence | Breast Neoplasms | Cell Line, Tumor | Cell Nucleus | Cell Transformation, Neoplastic | Chromatin | Chromosome Aberrations | DNA Damage | Female | Gene Dosage | Humans | Molecular Sequence Data | Mutation | Nerve Tissue Proteins | Nuclear Proteins | Ovarian Neoplasms | Trans-Activators | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: P01 CA64602
  • Agency: NCI NIH HHS, Id: P50 CA83639
  • Agency: NCI NIH HHS, Id: R01 CA112291-01A1
  • Agency: NCI NIH HHS, Id: U54 CA112970
  • Agency: NCI NIH HHS, Id: U54 CA112970-02

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.